Weizhen Wu

1.9k total citations
49 papers, 1.4k citations indexed

About

Weizhen Wu is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Weizhen Wu has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 16 papers in Molecular Biology and 12 papers in Genetics. Recurrent topics in Weizhen Wu's work include Mesenchymal stem cell research (8 papers), Pancreatic function and diabetes (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Weizhen Wu is often cited by papers focused on Mesenchymal stem cell research (8 papers), Pancreatic function and diabetes (6 papers) and Renal Transplantation Outcomes and Treatments (5 papers). Weizhen Wu collaborates with scholars based in China, United States and Canada. Weizhen Wu's co-authors include Ming Jen Tan, Shunliang Yang, Lianghu Huang, Jin Chen, Lianming Liao, Hu Zhao, Jinquan Cai, Tengyue Zeng, Zhixian Wu and Dong Wang and has published in prestigious journals such as Blood, Diabetes Care and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Weizhen Wu

48 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weizhen Wu China 21 603 339 260 249 175 49 1.4k
Dong Sun China 25 732 1.2× 455 1.3× 301 1.2× 138 0.6× 280 1.6× 129 1.9k
Francesco Bagaglia Italy 23 535 0.9× 345 1.0× 206 0.8× 84 0.3× 124 0.7× 40 1.5k
Xueyuan Bai China 27 846 1.4× 204 0.6× 335 1.3× 138 0.6× 120 0.7× 77 1.9k
Shaoyuan Cui China 24 709 1.2× 386 1.1× 107 0.4× 364 1.5× 126 0.7× 66 1.9k
Sumant S. Chugh United States 21 777 1.3× 238 0.7× 126 0.5× 111 0.4× 118 0.7× 40 2.2k
Miguel Arévalo Spain 24 909 1.5× 337 1.0× 163 0.6× 108 0.4× 324 1.9× 56 2.1k
Mirjana Jerkić Canada 26 523 0.9× 212 0.6× 158 0.6× 427 1.7× 414 2.4× 46 1.6k
Mark Warnock United States 16 323 0.5× 143 0.4× 194 0.7× 151 0.6× 88 0.5× 33 1.4k
Thati Madhusudhan Germany 18 497 0.8× 180 0.5× 94 0.4× 162 0.7× 137 0.8× 33 1.4k

Countries citing papers authored by Weizhen Wu

Since Specialization
Citations

This map shows the geographic impact of Weizhen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhen Wu more than expected).

Fields of papers citing papers by Weizhen Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weizhen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhen Wu. The network helps show where Weizhen Wu may publish in the future.

Co-authorship network of co-authors of Weizhen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Weizhen Wu. A scholar is included among the top collaborators of Weizhen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhen Wu. Weizhen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Shijie, Dan‐dan Ruan, Weizhen Wu, et al.. (2023). Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis. Pediatric Rheumatology. 21(1). 130–130. 11 indexed citations
3.
Chen, Jia, et al.. (2022). Clinical analysis of 2860 cases of diabetes in pregnancy: a single-center retrospective study. BMC Pregnancy and Childbirth. 22(1). 418–418. 4 indexed citations
5.
Fang, Chen, Yu Gan, Wenzhi He, et al.. (2021). Association of gestational diabetes mellitus with changes in gut microbiota composition at the species level. BMC Microbiology. 21(1). 147–147. 18 indexed citations
6.
Lü, Jun, Ling Zhu, Qiang Cui, et al.. (2018). Overexpression of ULK1 Represents a Potential Diagnostic Marker for Clear Cell Renal Carcinoma and the Antitumor Effects of SBI-0206965. EBioMedicine. 34. 85–93. 68 indexed citations
7.
Zeng, Tengyue, Libing Zhu, Min Liao, et al.. (2017). Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer. Medical Oncology. 34(2). 27–27. 75 indexed citations
8.
Wang, Dong, Libing Zhu, Min Liao, et al.. (2016). MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40. Oncology Reports. 36(3). 1285–1292. 23 indexed citations
9.
Barbieri, Christopher M., Xinkang Wang, Weizhen Wu, et al.. (2016). Factor XIIa as a Novel Target for Thrombosis: Target Engagement Requirement and Efficacy in a Rabbit Model of Microembolic Signals. Journal of Pharmacology and Experimental Therapeutics. 360(3). 466–475. 11 indexed citations
10.
Zheng, Kai, Weizhen Wu, Shunliang Yang, et al.. (2016). Treatment of radiation-induced acute intestinal injury with bone marrow-derived mesenchymal stem cells. Experimental and Therapeutic Medicine. 11(6). 2425–2431. 11 indexed citations
11.
Zheng, Kai, Weizhen Wu, Shunliang Yang, et al.. (2015). Bone marrow mesenchymal stem cell implantation for the treatment of radioactivity-induced acute skin damage in rats. Molecular Medicine Reports. 12(5). 7065–7071. 15 indexed citations
12.
Cai, Tian‐Quan, Weizhen Wu, Myung K. Shin, et al.. (2015). Factor XII full and partial null in rat confers robust antithrombotic efficacy with no bleeding. Blood Coagulation & Fibrinolysis. 26(8). 893–902. 20 indexed citations
14.
Shang, Jin, Min Wang, Qiu Li, et al.. (2014). Zucker Diabetic Fatty rats exhibit hypercoagulability and accelerated thrombus formation in the Arterio-Venous shunt model of thrombosis. Thrombosis Research. 134(2). 433–439. 16 indexed citations
15.
Wu, Zhixian, et al.. (2014). Prognostic factors for renal allograft survival in patients with immunoglobulin A nephropathy: A case control study. Molecular Medicine Reports. 9(4). 1179–1184. 3 indexed citations
17.
Wu, Zhixian, et al.. (2013). Prevalence and management of post-transplant anemia in long-term follow-up of Chinese kidney transplant recipients: a single-center report. European journal of medical research. 18(1). 45–45. 3 indexed citations
18.
Wu, Zhixian, Jinquan Cai, Jin Chen, et al.. (2013). Autologous bone marrow mononuclear cell infusion and hyperbaric oxygen therapy in type 2 diabetes mellitus: an open-label, randomized controlled clinical trial. Cytotherapy. 16(2). 258–265. 28 indexed citations
19.
Xu, Yiming, Weizhen Wu, Liangsu Wang, et al.. (2013). Differential profiles of thrombin inhibitors (heparin, hirudin, bivalirudin, and dabigatran) in the thrombin generation assay and thromboelastography in vitro. Blood Coagulation & Fibrinolysis. 24(3). 332–338. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026